Literature DB >> 23623566

Long-term follow-up of cemented fixed-bearing total knee arthroplasty in a Chinese population: a survival analysis of more than 10 years.

Bin Feng1, Xisheng Weng, Jin Lin, Jin Jin, Wei Wang, Guixing Qiu.   

Abstract

The aims of this study were to evaluate the long term clinical outcomes and survival rate of total knee arthroplasty (TKA) in Chinese population and the risk factors for failure. Between 1985 to 2001, 297 patients underwent primary TKAs with cemented fixed bearing platform in our center. Survival rate was 92.7% at 10 years, with reoperation of the implant as the endpoint, and 90.4% at 15 years. Main reasons for failure were infection and aseptic loosening. Clinical evaluation of 96 knees with HSS knee score showed the mean scores increased from 56.58 ± 11.05 preoperatively to 92.29 ± 10.95 postoperatively. RA patients had lower long-term survivorship compared with OA patients. Younger patients had better HSS scores. Patella strategy and posterior-cruciate-ligament (PCL) strategy had no effect on implant survivorship and clinical outcome. In conclusion, this was one of first studies showing valid long-term outcomes of primary TKA in Chinese.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  clinical outcome; fixed bearing platform; long term follow up; primary total knee arthroplasty; survivorship analysis

Mesh:

Substances:

Year:  2013        PMID: 23623566     DOI: 10.1016/j.arth.2013.03.009

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  8 in total

1.  An Analysis of Risk Factors for Short-Term Complication Rates and Increased Length of Stay Following Unicompartmental Knee Arthroplasty.

Authors:  Bryan D Haughom; William W Schairer; Michael D Hellman; Benedict U Nwachukwu; Brett R Levine
Journal:  HSS J       Date:  2015-01-27

2.  Survivorship at minimum 10-year follow-up of a rotating-platform, mobile-bearing, posterior-stabilised total knee arthroplasty.

Authors:  Michele Ulivi; Luca Orlandini; Valentina Meroni; Olmo Consonni; Valerio Sansone
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-06-18       Impact factor: 4.342

3.  Influence of the tourniquet on tibial cement mantle thickness in primary total knee arthroplasty.

Authors:  Tilman Pfitzner; Philipp von Roth; Ninja Voerkelius; Hermann Mayr; Carsten Perka; Robert Hube
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-09-25       Impact factor: 4.342

4.  Thirty-day Postoperative Complications following Primary Total Knee Arthroplasty: A Retrospective Study of Incidence and Risk Factors at a Single Center in China.

Authors:  Bin Feng; Jin Lin; Jin Jin; Wen-Wei Qian; Wei Wang; Xi-Sheng Weng
Journal:  Chin Med J (Engl)       Date:  2017-11-05       Impact factor: 2.628

5.  Does tourniquet use affect the periprosthetic bone cement penetration in total knee arthroplasty? A meta-analysis.

Authors:  Chao Lu; Min Song; Jin Chen; Congcong Li; Wenzheng Lin; Guozhu Ye; Gaoyi Wu; Anan Li; Yuning Cai; Huai Wu; Wengang Liu; Xuemeng Xu
Journal:  J Orthop Surg Res       Date:  2020-12-11       Impact factor: 2.359

6.  A study on dynamic monitoring, components, and risk factors of embolism during total knee arthroplasty.

Authors:  Kang Lu; Mingtao Xu; Wei Li; Kai Wang; Dawei Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

7.  No difference in clinical outcome and survivorship after total knee arthroplasty with patellar resurfacing and nonresurfacing after minimum 10-year follow-up.

Authors:  Bin Feng; Yi Ren; Jin Lin; Jin Jin; Wenwei Qian; Xisheng Weng
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

8.  Mid-long-term results of total knee arthroplasty followed by ipsilateral total hip arthroplasty versus total hip arthroplasty subsequent to ipsilateral total knee arthroplasty: a case-control analysis.

Authors:  Zunhan Liu; Wei-Nan Zeng; Zhenyu Luo; Enze Zhao; Hao Li; Zongke Zhou
Journal:  BMC Musculoskelet Disord       Date:  2021-06-24       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.